ASTANA, Kazakhstan, October 18. Kazakhstan's Qazaqstan Investment Corporation JSC has agreed with BGI Group (a Chinese genomics company) to create a joint investment fund, the Forebright Life Science Technology Fund, Trend reports.
In this regard, Chairman of the Board of QIC Aynur Kuatova, Vice Chairman of the Board of Investments of BGI Group Li Jixiang and Chairman of the Board of Forebright Capital Asia Liu Cheng signed an agreement on basic conditions (Term Sheet).
The newly established fund will be focused on financing innovative projects in the fields of multiomics technology and synthetic biology across the Middle East and Asia, including Kazakhstan.
The fund's target capitalization will be $200 million, according to the paper.
Previously, Qazaqstan Investment Corporation JSC signed a framework agreement on investment cooperation in the energy sector with China Huadian Overseas Investment Ltd. The agreement is aimed at ensuring the country’s energy security by introducing new capacities (including stations for renewable energy sources) as well as increasing the attractiveness of investment in the Republic of Kazakhstan for foreign capital, including in the energy industry.
As part of the visit of the President of Kazakhstan, Kassym-Jomart Tokayev to China, a number of documents were signed between Kazakhstan and China in the fields of energy, transport, investment, the transfer of production technologies, etc.
A total of 30 commercial documents were signed for a total of $16.54 billion.
